From October 29–31, 2026, ESOI Touchdown will bring together experts from radiology, oncology, research, and industry at the German Cancer Research Center (DKFZ) in Heidelberg. The program will focus on current developments in oncologic imaging – from artificial intelligence and innovative imaging strategies to multidisciplinary decision-making, screening, and the future of oncologic reporting.
For us at Mint Medical, this year’s ESOI Touchdown is particularly special: we have the home advantage! We look forward to meeting you in Heidelberg, exchanging ideas on current challenges in oncologic imaging, and showing you how mint Lesion supports structured, data-driven workflows in clinical routine and research.
mint Lesion supports you in your daily work:
- Standardized tumor response assessment in clinical trials
- AI-supported lung cancer screening
- AI-enhanced prostate imaging workflows
- AI-powered quantification of metastatic bone disease
- and much more.
Visit us at ESOI Touchdown to learn more.
See you in Heidelberg!
